Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV
dc.contributor.author | Lacombe-Duncan, Ashley | |
dc.contributor.author | Shokoohi, Mostafa | |
dc.contributor.author | Persad, Yasmeen | |
dc.contributor.author | Underhill, Angela | |
dc.contributor.author | Machouf, Nima | |
dc.contributor.author | Côté, Pierre | |
dc.contributor.author | Wheatley, Megan | |
dc.contributor.author | Gupta, Meenakshi | |
dc.contributor.author | Kyne, Luke T. | |
dc.contributor.author | Besharati, Amir A. | |
dc.contributor.author | Fung, Raymond | |
dc.contributor.author | Chan, L.Y.Louie | |
dc.contributor.author | Arbess, Gordon | |
dc.contributor.author | Bourns, Amy | |
dc.contributor.author | Nguyen, Quang | |
dc.contributor.author | Loutfy, Mona | |
dc.date.accessioned | 2022-04-08T18:08:01Z | |
dc.date.available | 2023-05-08 14:08:00 | en |
dc.date.available | 2022-04-08T18:08:01Z | |
dc.date.issued | 2022-04 | |
dc.identifier.citation | Lacombe-Duncan, Ashley ; Shokoohi, Mostafa; Persad, Yasmeen; Underhill, Angela; Machouf, Nima; Côté, Pierre ; Wheatley, Megan; Gupta, Meenakshi; Kyne, Luke T.; Besharati, Amir A.; Fung, Raymond; Chan, L.Y.Louie ; Arbess, Gordon; Bourns, Amy; Nguyen, Quang; Loutfy, Mona (2022). "Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV." HIV Medicine (4): 324-330. | |
dc.identifier.issn | 1464-2662 | |
dc.identifier.issn | 1468-1293 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/172092 | |
dc.description.abstract | IntroductionThis study aimed to characterize and identify factors associated with HIV care among transgender (trans) women living with HIV (TWLWH) in two urban centres in Canada.MethodsRetrospective data were collected from clinic charts of TWLWH aged 16 years and older across seven family medicine, endocrinology and/or HIV clinics in Montreal and Toronto, Canada, from 2018 to 2019 (n = 86). We assessed the proportion of individuals being ever engaged in HIV care [defined as having any recorded antiretroviral therapy (ART) regimen and/or viral load], current ART use, and most recent viral load (suppressed [<200 copies/ml] vs. unsuppressed) overall and compared across subgroups using χ2 tests.ResultsAll TWLWH in our sample [100.0%, 95% confidence interval (CI): 95.8–100.0%] were engaged in HIV care; most (93.0%, 95% CI: 85.4–97.4%) were currently using ART and most (93.4%, 95% CI: 85.3–97.8%) with complete data (n = 71/76) were virally suppressed. A higher proportion of trans women of colour (100.0%) reported current ART use compared with white trans women (76.9%, p = 0.017). A higher proportion of those with no documented history of injection drug use (IDU; 96.6%) were virally suppressed compared with those with a history of IDU (66.7%, p = 0.022). Although not statistically significant, 96.2% of those currently reporting feminizing hormone use were virally suppressed, compared with 85.0% of those not reporting use (p = 0.202).ConclusionsOnce engaged in HIV care, TWLWH in Canada appear to have excellent ART use and viral suppression. Findings can be leveraged to identify target populations to enhance HIV care and to further explore the relationship between gender‐affirming medical care and HIV care. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | antiretroviral therapy | |
dc.subject.other | gender affirmation | |
dc.subject.other | HIV care cascade | |
dc.subject.other | viral suppression | |
dc.subject.other | transgender women | |
dc.subject.other | transfeminine | |
dc.title | Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Microbiology and Immunology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172092/1/hiv13261.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172092/2/hiv13261_am.pdf | |
dc.identifier.doi | 10.1111/hiv.13261 | |
dc.identifier.source | HIV Medicine | |
dc.identifier.citedreference | Klein PW, Psihopaidas D, Xavier J, Cohen SM. HIV‐related outcome disparities between transgender women living with HIV and cisgender people living with HIV served by the health resources and services administration’s Ryan White HIV/AIDS program: a retrospective study. PLoS Med. 2020; 17 ( 5 ): e1003125. | |
dc.identifier.citedreference | Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta‐analysis, 2006–2017. Am J Public Health. 2019; 109 ( 1 ): e1 ‐ e8. | |
dc.identifier.citedreference | Government of Canada. Canada’s Health Care System 2018. Accessed August 22, 2021. https://www.canada.ca/en/health‐canada/services/health‐care‐system/reports‐publications/health‐care‐system/canada.html. | |
dc.identifier.citedreference | Wiewel EW, Torian LV, Merchant P, Braunstein SL, Shepard CW. HIV diagnoses and care among transgender persons and comparison with men who have sex with men: New York City, 2006–2011. Am J Public Health. 2016; 106 ( 3 ): 497 ‐ 502. | |
dc.identifier.citedreference | Baguso GN, Gay CL, Lee KA. Medication adherence among transgender women living with HIV. AIDS Care. 2016; 28 ( 8 ): 976 ‐ 981. | |
dc.identifier.citedreference | Kalichman SC, Hernandez D, Finneran S, Price D, Driver R. Transgender women and HIV‐related health disparities: falling off the HIV treatment cascade. Sex Health. 2017; 14 ( 5 ): 469 ‐ 476. | |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Statistics overview: HIV surveillance report 2018. Accessed August 21, 2021. https://www.cdc.gov/hiv/statistics/overview/index.html. | |
dc.identifier.citedreference | Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV 2021. Accessed January 17, 2022. https://clinicalinfo.hiv.gov/en/guidelines/adult‐and‐adolescent‐arv/whats‐new‐guidelines. | |
dc.identifier.citedreference | Lacombe‐Duncan A, Newman PA, Bauer GR, et al. Gender‐affirming healthcare experiences and medical transition among transgender women living with HIV: a mixed‐methods study. Sex Health. 2019; 16 ( 4 ): 367 ‐ 376. | |
dc.identifier.citedreference | Lindqvist EK, Sigurjonsson H, Mollermark C, Rinder J, Farnebo F, Lundgren TK. Quality of life improves early after gender reassignment surgery in transgender women. Eur J Plast Surg. 2017; 40 ( 3 ): 223 ‐ 226 | |
dc.identifier.citedreference | Steele LS, Daley A, Curling D, et al. LGBT identity, untreated depression, and unmet need for mental health services by sexual minority women and trans‐identified people. J Womens Health. 2017; 26 ( 2 ): 116 ‐ 127. | |
dc.identifier.citedreference | Empson S, Cuca YP, Cocohoba J, Dawson‐Rose C, Davis K, Machtinger EL. Seeking safety group therapy for co‐occurring substance use disorder and PTSD among transgender women living with HIV: a pilot study. J Psychoactive Drugs. 2017; 49 ( 4 ): 344 ‐ 351. | |
dc.identifier.citedreference | Lacombe‐Duncan A, Kia H, Logie CH, et al. A qualitative exploration of barriers to HIV prevention, treatment and support: perspectives of transgender women and service providers. Health Soc Care Community. 2020; 29 ( 5 ): e33 ‐ e46. | |
dc.identifier.citedreference | Kerkerian G, Kestler M, Carter A, et al. Attrition across the HIV cascade of care among a diverse cohort of women living with HIV in Canada. J Acquir Immune Defic Syndr. 2018; 79 ( 2 ): 226 ‐ 236. | |
dc.identifier.citedreference | O’Brien N, Godard‐Sebillotte C, Skerritt L, et al. Assessing gaps in comprehensive HIV care across settings of care for women living with HIV in Canada. J Women’s Health. 2020; 29 ( 11 ): 1475 ‐ 1485. | |
dc.identifier.citedreference | Adimora AA, Ramirez C, Poteat T, et al. HIV and women in the USA: what we know and where to go from here. Lancet. 2021; 397 ( 10279 ): 1107 ‐ 1115. | |
dc.identifier.citedreference | Lacombe‐Duncan A, Bauer GR, Logie CH, et al. The HIV care cascade among transgender women with HIV in Canada: a mixed‐methods study. AIDS Patient Care STDs. 2019; 33 ( 7 ): 308 ‐ 322. | |
dc.identifier.citedreference | Ontario Ministry of Health and Long Term Care (MOHLTC) HIV and AIDS in Ontario 2019. Accessed August 22, 2021. https://www.health.gov.on.ca/en/pro/programs/hivaids/. | |
dc.identifier.citedreference | Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019; 95: 103208. | |
dc.identifier.citedreference | Wilton J, Liu J, Sullivan A, et al. Trends in HIV care cascade engagement among diagnosed people living with HIV in Ontario, Canada: a retrospective, population‐based cohort study. PLoS One. 2019; 14 ( 1 ): e0210096. | |
dc.identifier.citedreference | Bauer GR, Travers R, Scanlon K, Coleman TA. High heterogeneity of HIV‐related sexual risk among transgender people in Ontario, Canada: a province‐wide respondent‐driven sampling survey. BMC Public Health. 2012; 12: 292. | |
dc.identifier.citedreference | Ronan W. 2021 officially becomes worst year in recent history for LGBTQ state legislative attacks as unprecedented number of states enact record‐shattering number of anti‐LGBTQ measures into law 2021. Accessed August 20, 2021. https://www.hrc.org/press‐releases/2021‐officially‐becomes‐worst‐year‐in‐recent‐history‐for‐lgbtq‐state‐legislative‐attacks‐as‐unprecedented‐number‐of‐states‐enact‐record‐shattering‐number‐of‐anti‐lgbtq‐measures‐into‐law. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.